Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: A Look at the Hot Topics from February

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

March 01, 2023

System Leverages Next Generation DeepOCTÔ Technology and Near Infrared Spectroscopy to Optimize Coronary Stent Placement in the Cardiac Catheterization Lab

News | Cath Lab

SpectraWAVE Secures 510(k) Clearance of HyperVue Intravascular Imaging System

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

March 01, 2023

Data from "Real-Time Atrial Appendage Assessment for LAAO-CLAAS Device Selection: Angiography vs TEE" was presented at Cardiovascular Research Technologies Conference (CRT)

News | Left Atrial Appendage (LAA) Occluders

Study Demonstrates Successful Device Size Selection When Assessing Left Atrial Appendage by Angiography Compared to TEE

February 27, 2023 — Conformal Medical, Inc. announced today the results from the CONFORMAL Early Feasibility Study (EFS) ...

February 27, 2023

Sponsored Content

Feature | Thrombectomy Devices

Redefining PE and VTE Intervention

Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...

June 01, 2026

News | Atrial Fibrillation

Abbott Announces U.S. and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms

February 2, 2023 — Abbott today announced two approvals as part of its growing suite of electrophysiology products in ...

February 02, 2023

Dr. Iani Patsias is an advanced heart failure and transplant cardiologist within the Memorial Healthcare System (Hollywood, FL).

News | Heart Failure

Memorial Cardiac and Vascular Institute Utilizes New Monitoring Technologies to Benefit Heart Failure Patients

February 2, 2023 — Technology is continuously evolving, and so is the approach taken by transplant cardiologists at Memo ...

February 02, 2023

Top 10 content for the month of January 2023

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: January's Most-read Content

Here is a recap of what DAIC viewers found most interesting during the month of January:

1. A Dietary Supplement ...

February 01, 2023

Sponsored Content

Blog | Contrast Media Injectors

BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

August 22, 2023

This image shows the mitral valve of the heart of a mouse that lacks the serotonin transporter (SERT) gene. The valve was stained with prico-sirius red to show collagen. SERT knockout mice had a thickened mitral valve compared to normal mice. Image courtesy of Columbia University Irving Medical Center

News | Cardiovascular Surgery

Columbia Researchers Find Link Between Serotonin and Heart Valve Disease

January 31, 2023 — Serotonin can impact the mitral valve of the heart and potentially accelerate a cardiac condition ...

January 31, 2023

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death

News | Catheter

Medtronic Recalls Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters for Potential Catheter Hub Defect

January 31, 2023 — The U.S. Food and Drug Administration (FDA) issued a statement announcing that Medtronic is recalling ...

January 31, 2023

The first US patient has been enrolled at Medstar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR to support FDA approval.

News | Drug-Eluting Balloons

MedAlliance Leads US Sirolimus DEB Race: First US Patient Enrolled into SELUTION SLR Coronary Sirolimus DEB Study

January 27, 2023 — The first US patient has been enrolled at Medstar Washington Hospital Center in the SELUTION4ISR ...

January 27, 2023

Sponsored Content

As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.

Blog | Enterprise Imaging

BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

August 10, 2023

$Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market$

News | Structural Heart

Abbott Receives FDA Approval for Navitor TAVI System

January 19, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's latest ...

January 19, 2023

SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.

News | Drug-Eluting Balloons

MedAlliance Selution SLR is the First DEB to Receive Coronary de novo IDE Approval, its Fourth FDA IDE DEB Approval

January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA ...

January 12, 2023

A heart-pacing lead is a small catheter with electrodes.

News | Leads Implantable Devices

Cardiac Pacing Leads Market Will Reach $394 million by 2029

January 3, 2023 — The market has been studied for the below mentioned-segmentation and regional analysis for North ...

January 03, 2023

Sponsored Content

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians

Case Study | Baylor Scott and White Heart Hospital

Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

May 05, 2023

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC's Top 20 from 2022

As 2022 comes to a close, the Diagnostic and Interventional Cardiology team takes a look at the year's most viewed ...

January 02, 2023

News | Diagnostic and Interventional Cardiology DAIC

Happy New Year from DAIC

The DAIC team wishes you a very happy and safe New Year!

January 01, 2023

The AcQCross Qx system combines the dilator and needle needed to perform left-atrial appendage closure procedures, eliminating the need to swap equipment mid-surgery while crossing into the left side of the heart. (Pixabay)

News | Left Atrial Appendage (LAA) Occluders

Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic

December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

December 22, 2022